Shandong Yikang Pharmaceutical Co., Ltd. is located at No. 3288 Yikang Avenue, Tengzhou City. Originally founded as the Experimental Pharmaceutical Factory of Shandong Academy of Medical Sciences, the company was restructured into its current form in January 1999. It employs 431 staff members and possesses total assets of RMB 496 million. The company operates 11 pharmaceutical production workshops, covering eight dosage forms including active pharmaceutical ingredients (APIs), small-volume injections, and oral liquids, with a total of 83 approved drug varieties. Its core focus lies in therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-tumor treatments, and vitamins and minerals.
The company produces APIs and eight dosage forms: small-volume injections, oral liquids, oral solutions, syrups, tablets, granules, dry suspensions, and hard capsules. Its product portfolio comprises 83 varieties across therapeutic categories including cardiovascular and cerebrovascular system medications, digestive system medications, respiratory system medications, anti-infective drugs, antipyretic and analgesic drugs, and anti-tumor drugs, as well as 4 API varieties. A total of 19 products are available for international trade, with drug export registration completed in 8 countries and regions across Africa and Southeast Asia.
